ORIC Pharmaceuticals, Inc. (ORIC) Misses Q4 EPS by 1c

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q4 EPS of ($0.49), $0.01 worse than the analyst estimate of ($0.48).

For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.

You May Also Be Interested In

• ORIC Pharmaceuticals (ORIC) PT Raised to $27 at H.C. Wainwright
• Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
• Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c